908 Devices Inc Ordinary Shares MASS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MASS is a good fit for your portfolio.
News
-
908 Devices Announces MX908 Integration Capabilities
-
908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook
-
908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System
-
908 Devices to Participate in Upcoming Investor Conferences
-
908 Devices Awarded $10.4M Order from the United States Air Force for its Handheld MX908 Device
-
908 Devices to Report Third Quarter Financial Results on November 7, 2023
-
908 Devices Enters Initial Production Phase of US Department of Defense Aerosol and Vapor Chemical Agent Detector Program
-
908 Devices Launches MAVERICK for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters
Trading Information
- Previous Close Price
- $7.15
- Day Range
- $7.05–7.53
- 52-Week Range
- $4.85–10.97
- Bid/Ask
- $7.05 / $7.38
- Market Cap
- $238.96 Mil
- Volume/Avg
- 65,055 / 151,861
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.98
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 68
- Website
- https://www.908devices.com
Valuation
|
Metric
|
MASS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.41 |
Price/Sales | 4.98 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MASS
|
|---|---|
Quick Ratio | 7.20 |
Current Ratio | 8.06 |
Interest Coverage | −165.83 |
Quick Ratio
MASS
Profitability
|
Metric
|
MASS
|
|---|---|
Return on Assets (Normalized) | −13.00% |
Return on Equity (Normalized) | −16.09% |
Return on Invested Capital (Normalized) | −17.40% |
Return on Assets
MASS
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ABT
| Abbott Laboratories | Qwrtctk | $182.2 Bil | |
SYK
| Stryker Corp | Mtlr | $109.4 Bil | |
MDT
| Medtronic PLC | Xpwt | $105.1 Bil | |
BSX
| Boston Scientific Corp | Bssjmjl | $80.3 Bil | |
DXCM
| DexCom Inc | Lct | $45.0 Bil | |
EW
| Edwards Lifesciences Corp | Ssxnqrk | $42.1 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Mnwlx | $24.3 Bil | |
PHG
| Koninklijke Philips NV ADR | Vqblpd | $18.6 Bil | |
ALGN
| Align Technology Inc | Dyvtkw | $16.6 Bil | |
PODD
| Insulet Corp | Lbtgqh | $13.2 Bil |